The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Pulmonary hypertension in the crest syndrome variant of systemic sclerosis
Abstract
Pulmonary hypertension (PHT) occurred in 59 (9%) of 673 systemic sclerosis patients seen between 1963 and 1983. In 30 patients, all with the CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias), the pulmonary hypertension was isolated, i.e., independent of other pulmonary or cardiac conditions. In 20 patients, isolated PHT was demonstrated by cardiac catheterization. All had normal or only mildly decreased lung volumes, and mild or no pulmonary interstitial fibrosis on chest roentgenogram. In comparison with 287 CREST syndrome patients without PHT, these 20 patients had markedly reduced diffusing capacity for carbon monoxide (DLco) (mean 39% of predicted normal). In 6 patients, the low DLco antedated clinical evidence of PHT by 1–6 years. At autopsy there was marked intimal fibrosis with hyalinization and smooth muscle hypertrophy in the small‐ and medium‐sized arteries, without significant parenchymal fibrosis or inflammation. Patients with isolated PHT did not respond favorably to vasodilators and had a very poor prognosis, with a 2‐year cumulative survival rate of 40%. A DLco < 45% of predicted in the absence of pulmonary interstitial fibrosis may be an important predictor of the subsequent development of isolated PHT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Pathologic observations in systemic sclerosis (scleroderma)
D'Angelo, W. A., Fries, J. F., Masi., A. T., & Shulman, L. E. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90044-8 · Cited by 1,111
Diversity of antinuclear antibodies in progressive systemic sclerosis
Tan, E. M., Rodnan, G. P., Garcia, I., Moroi, Y., Fritzler, M. J., & Peebles, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230602 · Cited by 524
Self-citationCANNON, P. J., HASSAR, M., CASE, D. B., CASARELLA, W. J., SOMMERS, S. C., & LeROY, E. C. (1974) · Medicine · doi:10.1097/00005792-197401000-00001 · Cited by 343
D-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma): A Retrospective Analysis
STEEN, V. D., MEDSGER, T. A., & RODNAN, G. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-652 · Cited by 322
Self-citationEpidemiology of Systemic Sclerosis (Scleroderma)
MEDSGER, T. A., & MASI, A. T. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-5-714 · Cited by 275
Self-citationUngerer, R. G., Tashkin, D. P., Furst, D., Clements, P. J., Gong, H., Bein, M., Smith, J. W., Roberts, N., & Cabeen, W. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91169-5 · Cited by 262
TRAUB, Y. M., SHAPIRO, A. P., RODNAN, G. P., MEDSGER, T. A., MCDONALD, R. H., STEEN, V. D., OSIAL, T. A., & TOLCHIN, S. F. (1983) · Medicine · doi:10.1097/00005792-198311000-00001 · Cited by 237
Self-citationSteen, V. D., Ziegler, G. L., Rodnan, G. P., & Medsger, T. A. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270202 · Cited by 225
Self-citationRecommended standardized procedures of pulmonary function testing
Standardization, E. (1978) · Medical Entomology and Zoology · Cited by 150
Pulmonary Function in Progressive Systemic Sclerosis
Owens, G. R., Fino, G. J., Herbert, D. L., Steen, V. D., Medsger, T. A., Pennock, B. E., Cottrell, J. J., Rodnan, G. P., & Rogers, R. M. (1983) · CHEST Journal · doi:10.1378/chest.84.5.546 · Cited by 128
Self-citationCarbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis
Peters-Golden, M. L., Wise, R. A., Hochberg, M. C., Stevens, M. B., & Wigley, F. M. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90183-9 · Cited by 88
Qualitative testing for circulating immune complexes by use of zone electrophoresis on agarose.
Kelly, R. H., Scholl, M., Harvey, V. S., & Devenyi, A. G. (1980) · Clinical Chemistry · doi:10.1093/clinchem/26.3.0396 · Cited by 36
Cited by
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Gomez Sanchez, M. A., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138
Writing Committee Members, McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,093
Metadata
- Authors
- Stupi, A. M., Steen, V. D., Owens, G. R., Barnes, E. L., Rodnan, G. P., & Medsger, T. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1986-04
- Volume
- 29
- Issue
- 4
- Pages
- 515-524
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2018426574
- Cited by
- 367
- References
- 13
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.